5 research outputs found
第925回千葉医学会例会・第20回千葉大学医学部放射線医学教室同門会例会
Teriflunomide does not affect cell death in cultured primary microglia. Isolated microglia were treated with LPS (100 ng/ml) and different concentrations of teriflunomide (0.25–5 μM) for 12, 48, or 72 h followed by staining with propidium iodide (PI). (A, B, C) The percentage of gated PI+ CD11b/c+ cells is presented as mean + SD (n = 4). (TIF 718 kb
Additional file 3: Figure S1. of In vitro evaluation of physiologically relevant concentrations of teriflunomide on activation and proliferation of primary rodent microglia
Teriflunomide inhibits rodent T cell proliferation. Single-cell suspensions from spleens of adult Sprague-Dawley rats (Crl:CD) were prepared in complete IMDM medium. Freshly isolated rat CD4+ T cells were labeled with 2.5 μM CFSE, stimulated with plate-bound anti-CD3/CD28 mAb and treated with different concentrations of teriflunomide (0.25–5 μM) for 65–72 h. Control presents unstimulated CFSE-labeled cells. (A) Total number of T cells as shown in histograms for 0.5 μM teriflunomide was determined by flow cytometry. (B) For comparison of proliferation, the number of proliferating T cells (n = 4) repeated measures ANOVA with Bonferroni’s multiple comparison t test were used. Significant effects are indicated by asterisks (***p < 0.001). (TIF 162 kb
Additional file 2: of Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
Clinical course of WT and α4−/− mice. EAE severity was monitored in WT and α4−/− mice following immunization with MOG35–55 in CFA. WT mice showed the signs of classical EAE whereas α4−/− mice had an ataxic EAE syndrome. Data is represented as mean clinical score + SEM (n = 6). (TIFF 419 kb
Additional file 4: of Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
ELISA of astrocyte culture supernatants. Concentration of CCL2, CCL20, and IL-6 was measured in the culture supernatants of astrocytes cultured in medium, Th1 and Th17 supernatants. Since we did not remove T cells factors, to exclude any background resulting from T cells, supernatants used in these experiments to stimulate astrocytes were also tested for these factors. CCL2 and IL-6 was not detected in T cell supernatants whereas little amount of CCL20 was detected in Th17 supernatants. Actual concentration of CCL20 released by astrocytes was calculated by subtracting the concentrations obtained for Th17 supernatants. The results are mean ± SEM (n = 4) with *p ≤ 0.05 and **p ≤ 0.01. (TIFF 216 kb
Additional file 5: of Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
Inhibition of reactive astrocytosis affects Th17 infiltration into the CNS. Expression of Rorc mRNA was measured in the spinal cord of wild-type (WT) or GFAP TK (Tg) mice with established EAE where at day 7 following onset of clinical symptoms the mice were either challenge with PBS (controls) or ganciclovir (GCV) to deplete astrocytes. The basal expression was adjusted to WT-PBS controls and fold changes in Rorc mRNA expression was determined for the other groups. Each point represents data from one mouse. Here we used Mann-Whitney test. (TIFF 276Â kb